Hostname: page-component-78c5997874-4rdpn Total loading time: 0 Render date: 2024-11-20T03:32:52.676Z Has data issue: false hasContentIssue false
  • English
  • Français

UNIVERSAL CYTOMEGALOVIRUS SCREENING: TIME FOR REAPPRAISAL?

Published online by Cambridge University Press:  18 November 2014

BRIOHNY J HUTCHINSON ,
RICARDO PALMA-DIAS  and
SUSAN P WALKER
BRIOHNY J HUTCHINSON*
Affiliation:
Department of Perinatal Medicine, Mercy Hospital for Women, 163 Studley Road, Heidelberg, VIC 3084, Australia.
RICARDO PALMA-DIAS
Affiliation:
Department of Obstetrics and Gynaecology, University of Melbourne, Parkville, VIC, Australia. Pregancy Research Centre, Royal Womens' Hospital, Parkville, VIC, Australia. Fetal Management Unit, Royal Women's Hospital, Flemington Rd, Parkville, Melbourne, VIC, Australia.
SUSAN P WALKER
Affiliation:
Department of Perinatal Medicine, Mercy Hospital for Women, 163 Studley Road, Heidelberg, VIC 3084, Australia. Department of Obstetrics and Gynaecology, University of Melbourne, Parkville, VIC, Australia. Fetal Management Unit, Royal Women's Hospital, Flemington Rd, Parkville, Melbourne, VIC, Australia.
*
Dr Briohny Hutchinson, Maternal Fetal Medicine Fellow, Mercy Hospital for Women, 163 Studley Rd, Heidelberg, 3084, Victoria, Australia. Email: [email protected]
Get access Rights & Permissions [Opens in a new window]

Extract

Congenital cytomegalovirus (CMV) infection is now the commonest infective cause of neurological handicap. Arguably, there is no other single contributor to developmental disability where a greater opportunity, and imperative, exists to improve outcomes than CMV. CMV is the most common intrauterine infection and congenital CMV is the leading non-inherited cause of sensorineural deafness. The public health impact of CMV is significant: the overall birth prevalence of congenital CMV is estimated at 0.64%, with 11% of live born infants displaying symptoms.

Type
Review Article
Information
Fetal and Maternal Medicine Review , Volume 25 , Issue 2 , May 2014 , pp. 117 - 133
Copyright
Copyright © Cambridge University Press 2014 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1.Cannon, MJ, Davis, KF. Washing our hands of the congenital cytomegalovirus disease epidemic. BMC Publ Health 2005; 5: 70.Google Scholar
2.Lazzarotto, T, Guerra, B, Gabrielli, L, Lanari, M, Landini, MP. Update on the prevention, diagnosis and management of cytomegalovirus infection during pregnancy. CMI 2011; 17: 1285–93.Google Scholar
3.Kenneson, A, Cannon, MJ. Review and meta-analysis of the epidemiology of congenital cytomegalovirus (CMV) infection. Rev Med Virol 2007; 13 (4): 253–76.Google Scholar
4.UK National Screening Committee. CMV screening policy review summary. April 2012.Google Scholar
5.Pass, RF, Zhang, C, Evans, A, Simpson, T, Andrews, W, Huang, MIet al.Vaccine prevention of maternal cytomegalovirus infection. N Engl J Med 2009; 13 (12): 1191–9.Google Scholar
6.Swanson, EC, Schleiss, MR. Congenital cytomegalovirus infection: new prospects for prevention and therapy. Pediatr Clin N Am 2013; 60: 335–49.Google Scholar
7.Adler, S, Nigro, G. Prevention of maternal-fetal transmission of cytomegalovirus. Clin Infect Dis. 2013; 57 (Suppl. 4): S189–92.Google Scholar
8.Wang, C, Zhang, X, Bialek, S, Cannon, MJ. Attribution of congenital cytomegalovirus infection to primary versus non-primary maternal infection. Clin Infect Dis 2011; 13 (2): e11–3.Google Scholar
9.Lugnér, AK, Mollema, L, Ruijs, WL, Hahné, SJ. A cost-utility analysis of antenatal screening to prevent congenital rubella syndrome. Epidemiol Infect 2010; 13 (8): 1172–84.Google Scholar
10.Arevalo, JA, Washington, AE. Cost-effectiveness of prenatal screening and immunization for hepatitis B virus. JAMA. 1988; 13 (3): 365–9.Google Scholar
11.Blencowe, H, Cousens, S, Kamb, M, Berman, S, Lawn, JE. Lives saved tool supplement detection and treatment of syphilis in pregnancy to reduce syphilis related stillbirths and neonatal mortality. BMC Publ Health 2011; 13 (3): S9.Google Scholar
12.Walker, SP, Palma-Dias, R, Wood, EM, Shekleton, P, Giles, ML. Cytomegalovirus in pregnancy: to screen or not to screen. BMC Pregnancy Child Birth 2013; 13: 96.CrossRefGoogle ScholarPubMed
13.Dollard, SC, Grosse, SD, Ross, DS. New estimates of the prevalence of neurological and sensory sequelae and mortality associated with congenital cytomegalovirus infection. Rev Med Virol 2007; 13 (5): 355–63.Google Scholar
14.Yinon, Y, Farine, D, Yudin, M. Screening, diagnosis and management of cytomegalovirus in pregnancy. Obs Gynae Survey 2011; 33: 736–43.Google Scholar
15.Fowler, KB. Congenital cytomegalovirus infection: audiologic outcome. Clin Infect Dis 2013; 57 (Suppl. 4): S182–4.CrossRefGoogle ScholarPubMed
16.Picone, O, Vaulop-Fellows, C, Cordier, AG, guittan, S, Senat, MV, Fuchs, Fet al.A series of 238 cytomegalovirus primary infections during pregnancy: description and outcome. Prenat Diag 2013; 33: 751–8.Google Scholar
17.Enders, G, Daiminger, A, Bäder, U, Exler, S, Enders, M. Intrauterine transmission and clinical outcome of 248 pregnancies with primary cytomegalovirus infection in relation to gestational age. J Clin Virol 2011; 52 (3):244–6.Google Scholar
18.Bodéus, M, Zech, F, Hubinont, C, Bernard, P, Goubau, P. Human cytomegalovirus in utero transmission: follow-up of 524 maternal seroconversions. J Clin Virol 2010; 13: 201–2.Google Scholar
19.Pass, RF, Fowler, KB, Sb, B. Congenital cytomegalovirus infection following first trimester maternal infection: symptoms at birth and outcome. J Clin Virol 2006; 13 (2): 216–20.Google Scholar
20.Johnson, JM, Anderson, BL. Cytomegalovirus: should we screen pregnant women for primary infection? Am J Perinatol 2013; 30: 121.Google Scholar
21.Nigro, G, Adler, S. Cytomegalovirus infections during pregnancy. Curr Opin Obstet Gynecol 2011; 23: 123–8.CrossRefGoogle ScholarPubMed
22.Maidji, E, Nigro, G, Tabata, T, McDonagh, S, Nozawa, N, Shiboski, Set al.Antibody treatment promotes compensation for human cytomegalovirus-induced pathogenesis and a hypoxia-like condition in placentas with congenital infection. Am J Pathol 2010; 13 (3): 1298–310.Google Scholar
23.Vauloup-Fellous, C, Picone, O, Cordier, AG. Does hygiene counseling have an impact on the rate of CMV primary infection during pregnancy? Results of a 3-year prospective study in a French hospital. J Clin Virol 2009; 13 (4): S49–53.CrossRefGoogle Scholar
24.Nigro, G, Adler, SP, La Torre, R, Best, AM. Congenital cytomegalovirus collaborating group. Passive immunization during pregnancy for congenital cytomegalovirus infection. N Engl J Med 2005; 13 (13): 1350–62.Google Scholar
25.Cahill, AG, Odibo, AO, Stamilo, DM, Macones, GA. Screening and treating for primary cytomegalovirus infection in pregnancy: where do we stand? A decision-analytic and economic analysis. Am J Obstet Gynecol 2009; 13 (466): e1–7.Google Scholar
26.Adler, SP. Immunisation to prevent congenital cytomegalovirus infection. Br Med Bull 2013; 107: 57–68.Google Scholar
27.Hyde, TB, Schmid, DS, Cannon, MJ. Cytomegalovirus seroconversion rates and risk factors: implications for congenital CMV. Rev Med Virol 2010; 13 (5): 311.Google Scholar
28.Adler, SP, Finney, JW, Manganello, AM, Best, AM. Prevention of child- to- mother transmission of cytomegalovirus among pregnant women. J Pediatr 2004; 145: 485–91.Google Scholar
29.Centres for Disease Control and Prevention. Preventing Congenital CMV Infection. 2014. http://www.cdc.gov/cmv/prevention.html. accessed 17 Feb 2014.Google Scholar
30.Francisse, S, Reveland, P, De Maerelaer, V, Strebelle, E, Englert, Y, Liesnard, C. Human cytomegalovirus seroprevalence and risk of seroconversion in a fertility clinic population. Obstet Gynecol 2009; 114: 285–91.Google Scholar
31.Picone, O, Vauloup-Fellous, C, Cordier, AG, Parent Du Châtelet, I, Senat, MV, Frydman, Ret al.A 2-year study on cytomegalovirus infection during pregnancy in a French hospital. BJOG 2009; 13 (6): 818–23.11.Google Scholar
32.Adler, S. Screening for cytomegalovirus in pregnancy Infect Dis Obstet Gynecol 2011; 2011: 1–9.Google Scholar
33.Lazzarotto, T, Guerra, B, Lanari, M, Gabrielli, L, Landini, MP. New advances in the diagnosis of congenital CMV infection. J Clin Virol 2008; 13: 192–7.CrossRefGoogle Scholar
34.Liesnard, C, Donner, C, Brancart, F. Prenatal diagnosis of congenital cytomegalovirus infection: prospective study of 237 pregnancies at risk. Obstet Gynecol 2000; 13 (6 Pt 1): 881–8.Google Scholar
35.Gabbay-Ben Ziv, R, Yogev, Y, Peled, Y. Congenital cytomegalovirus infection following antenatal negative diagnostic amniotic fluid analysis - a single center experience. J Matern Fetal Neonatal Med 2012; 13 (9): 1787–90.Google Scholar
36.Picone, O, Costa, JM, Leruez-Ville, M, Ernault, P, Olivi, M, Ville, Y. Cytomegalovirus (CMV) glycoprotein B genotype and CMV DNA load in the amniotic fluid of infected fetuses. Prenat Diag. 2004; 15: 24 (12): 1001–6.Google Scholar
37.Lipitz, S, Achiron, R, Zalel, Y, Mendelson, E, Tepperbeg, M, Gamzu, R. Outcome of pregnancies with vertical transmission of primary cytomegalovirus infection. Obstet Gynecol 2002; 100: 428–33.Google Scholar
38.Guerra, B, Simonazzi, G, Puccetti, C. Ultrasound prediction of symptomatic congenital cytomegalovirus infection. Am J Obstet Gynecol 2008; 13 (380): e1–7.Google Scholar
39.Benoist, G, Salomon, LJ, Jacquemard, F, Daffos, F, Ville, Y. The prognostic value of ultrasound abnormalities and biological parameters in blood of foetuses infected with cytomegalovirus. BJOG 2008; 115 (7): 823–9.Google Scholar
40.Benoist, G, Salomon, LJ, Mohlo, M. Cytomegalovirus-related fetal brain lesions: comparison between targeted ultrasound examination and magnetic resonance imaging. Ultrasound Obstet Gynecol 2008; 13 (7): 900–5.Google Scholar
41.Piccone, O, Simon, I, Benachi, A. Comparison between ultrasound and magnetic resonance imaging in assessment of fetal cytomegalovirus infection. Prenat Diag 2008; 28: 753–8.CrossRefGoogle Scholar
42.Buxmann, H, Stackelberg, OM, Schlößer, RL, Enders, G, Gonser, M, Meyer-Wittkopf, Met al.Use of cytomegalovirus hyperimmunoglobulin for prevention of congenital cytomegalovirus disease: a retrospective analysis. J Perinat Med 2012; 40: 439–46.Google Scholar
43.Revello, MG, Lazzarotto, T, Guerra, B, Spinillo, A, Ferrazzi, E, Kutermann, Aet al.A randomized trial of hyperimmune globulin to prevent congenital cytomegalovirus. N Engl J Med 2014; 370: 1316–26.Google Scholar
44.Visentin, S, Manara, R, Milanese, L. Early primary cytomegalovirus infection in pregnancy: maternal hyperimmunoglobulin therapy improves outcomes among infants at 1 year of age. Clin Infect Dis 2012; 13 (4): 497–503.Google Scholar
45.Nigro, G, Adler, SP, La Torre, R, Best, AM. Congenital cytomegalovirus collaborating group. Passive immunization during pregnancy for congenital cytomegalovirus infection. N Engl J Med. 2005; 13 (13): 1350–62.Google Scholar
46.Nigro, G, Adler, SP, Parruti, G. Immunoglobulin therapy of fetal cytomegalovirus infection occurring in the first half of pregnancy–a case-control study of the outcome in children. J Infect Dis. 2012; 13 (2): 215–27.Google Scholar
47.Nigro, G, Adler, SP. Hyperimmunoglobulin for prevention of congenital cytomegalovirus disease. Clin Infect Dis. 2013; 57 (Suppl. 4): S193–5.Google Scholar
48.Jacquemard, F, Yamamoto, M, Costa, JM. Maternal administration of valaciclovir in symptomatic intrauterine cytomegalovirus infection. BJOG 2007; 13 (9): 1113–21.Google Scholar
49.Kimberlin, DW. Short-term vs. long-term valganciclovir therapy for symptomatic congenital cmv infections : in Abstract proceedings at the Infectious Diseases Society of America (IDSA) 2013 meeting. Study CASG112 Clinical trials.gov Identifier: NCT00466817.Google Scholar
50.Oliver, SE, Cloud, GA, Sánchez, PJ, Demmler, GJ, Dankner, W, Shelton, M. National institute of allergy, infectious diseases collaborative antiviral study group neurodevelopmental outcomes following ganciclovir therapy in symptomatic congenital cytomegalovirus infections involving the central nervous system. J Clin Virol. 2009; 46 (Suppl. 4): S22–6.Google Scholar
51.Fowler, KB, Boppana, SB. Congenital cytomegalovirus (CMV) infection and hearing deficit. J Clin Virol 2005; 35: 226–31.Google Scholar
52.Townsend, CL, Forsgren, M, Ahlfors, K, Ivarsson, SA, Tookey, PA, Peckham, CS. Longterm outcomes of congenital cytomegalovirus infection in Sweden and the United Kingdom. Clin Infect Dis 2013; 56 (9): 1232.Google Scholar
53.Fowler, KB, Tolan, RW, Ahmed, Aet al. Interim findings of the importance of congenital cytomegalovirus infection in the eitiology of childhood hearing loss. In: Abstract proceedings of the 13th International CMV/Beta herpesvirus Workshop, Nuremburg, Germany, 14–17 May 2011.Google Scholar